These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12927774)

  • 1. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP.
    Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC
    Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.
    Tomita N; Horiuchi M; Tomita S; Gibbons GH; Kim JY; Baran D; Dzau VJ
    Am J Physiol; 1998 Aug; 275(2):F278-84. PubMed ID: 9691019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
    Ahn JD; Morishita R; Kaneda Y; Kim HS; Chang YC; Lee KU; Park JY; Lee HW; Kim YH; Lee IK
    Gene Ther; 2002 Dec; 9(24):1682-92. PubMed ID: 12457282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.
    Maeshima Y; Kashihara N; Yasuda T; Sugiyama H; Sekikawa T; Okamoto K; Kanao K; Watanabe Y; Kanwar YS; Makino H
    J Clin Invest; 1998 Jun; 101(11):2589-97. PubMed ID: 9616230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells.
    Ahn JD; Kim CH; Magae J; Kim YH; Kim HJ; Park KK; Hong S; Park KG; Lee IK; Chang YC
    Biochem Biophys Res Commun; 2003 Oct; 310(4):1048-53. PubMed ID: 14559221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
    Tomita N; Kim JY; Gibbons GH; Zhang L; Kaneda Y; Stahl RA; Ogborn M; Venderville B; Morishita R; Baran D; Dzau VJ
    Int J Mol Med; 2004 May; 13(5):629-36. PubMed ID: 15067361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of novel isoforms of human DP-1: DP-1{alpha} regulates the transcriptional activity of E2F1 as well as cell cycle progression in a dominant-negative manner.
    Ishida H; Masuhiro Y; Fukushima A; Argueta JG; Yamaguchi N; Shiota S; Hanazawa S
    J Biol Chem; 2005 Jul; 280(26):24642-8. PubMed ID: 15863509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells.
    Tsuboi N; Yoshida H; Kawamura T; Furukawa Y; Hosoya T; Yamada H
    Kidney Int; 2000 Apr; 57(4):1581-9. PubMed ID: 10760093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
    J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition on phenotypic transformation of detrusor smooth muscle cells after bladder outlet obstruction by E2F decoy strategy].
    Gong Y; Du CJ; Ding LL; Song B; Jin XY
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):829-32. PubMed ID: 17565867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of E2F-4/DP-1-stimulated transcription by p202.
    Choubey D; Gutterman JU
    Oncogene; 1997 Jul; 15(3):291-301. PubMed ID: 9233764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T
    Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction between DP-1 and p53.
    Sørensen TS; Girling R; Lee CW; Gannon J; Bandara LR; La Thangue NB
    Mol Cell Biol; 1996 Oct; 16(10):5888-95. PubMed ID: 8816502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L; Dimri GP; Campisi J; Chen KY
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.
    Hashiya N; Aoki M; Tachibana K; Taniyama Y; Yamasaki K; Hiraoka K; Makino H; Yasufumi K; Ogihara T; Morishita R
    Biochem Biophys Res Commun; 2004 Apr; 317(2):508-14. PubMed ID: 15063786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the G1/S transition phase in mesangial cells by E2F1.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.
    Tomita T; Kunugiza Y; Tomita N; Takano H; Morishita R; Kaneda Y; Yoshikawa H
    Int J Mol Med; 2006 Aug; 18(2):257-65. PubMed ID: 16820932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.